Detalhe da pesquisa
1.
Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Circulation;
142(24): 2329-2337, 2020 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33115278
2.
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized Trial.
Ann Intern Med;
173(6): 436-444, 2020 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32687741
3.
Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
Thromb Haemost;
124(4): 297-306, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37591289
4.
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel.
Clin Res Cardiol;
2024 May 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38740722
5.
Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range.
J Clin Med;
12(9)2023 Apr 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37176615
6.
Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis.
EuroIntervention;
18(16): e1328-e1338, 2023 Apr 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36785947
7.
The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes.
Eur Heart J Cardiovasc Pharmacother;
9(3): 231-239, 2023 04 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36434779
8.
Modified balloons to prepare severely calcified coronary lesions before stent implantation: a systematic review and meta-analysis of randomized trials.
Clin Res Cardiol;
2023 Nov 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37930402
9.
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Thromb Haemost;
123(4): 464-477, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36442805
10.
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial.
Clin Res Cardiol;
112(4): 518-528, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35789430
11.
Alkaline phosphatase and prognosis in patients with diabetes mellitus and ischemic heart disease.
Clin Chim Acta;
533: 1-7, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35690085
12.
One-Year Ischemic and Bleeding Events According to Renal Function in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Third-Generation Antiplatelet Drugs.
Am J Cardiol;
176: 15-23, 2022 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35606172
13.
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y12 Inhibitor Thereafter.
J Atheroscler Thromb;
29(7): 1001-1019, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34248087
14.
Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial.
J Atheroscler Thromb;
29(5): 747-761, 2022 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33867409
15.
Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis.
Clin Res Cardiol;
111(7): 827-837, 2022 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35476138
16.
Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromes.
Coron Artery Dis;
33(3): 213-221, 2022 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35102066
17.
Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes - A Post-hoc Analysis of the ISAR-REACT 5 Trial.
J Am Heart Assoc;
11(24): e027257, 2022 12 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36515247
18.
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy.
Cardiovasc Revasc Med;
41: 122-128, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35045943
19.
Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trial.
Eur Heart J Cardiovasc Pharmacother;
8(7): 687-694, 2022 Sep 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35191982
20.
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes.
Rev Esp Cardiol (Engl Ed);
75(9): 747-755, 2022 Sep.
Artigo
em Inglês, Espanhol
| MEDLINE
| ID: mdl-34961732